DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval versus Standard Bridging Therapy
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose The benefit regarding co-treatment with intravenous (IV) thrombolysis before mechanical thrombectomy in acute ischemic stroke with large vessel occlusion remains unclear. To test the hypothesis that clinical outcome of ischemic stroke patients with intracranial internal carotid artery, middle cerebral artery or basilar artery occlusion treated with direct endovascular thrombectomy within 4.5 hours will be non-inferior compared with that of standard bridging IV thrombolysis followed by endovascular thrombectomy. Methods To randomize 780 patients 1:1 to direct thrombectomy or bridging IV thrombolysis with thrombectomy. An international-multicenter prospective randomized open label blinded endpoint trial (PROBE) (ClincalTrials.gov identifier: NCT03494920). Results Primary endpoint is functional independence defined as modified Rankin Scale (mRS) 0–2 or return to baseline at 90 days. Secondary end points include ordinal mRS analysis, good angiographic reperfusion (modified Thrombolysis in Cerebral Infarction score [mTICI] 2b–3), safety endpoints include symptomatic intracerebral hemorrhage and death. Conclusions DIRECT-SAFE will provide unique information regarding the impact of direct thrombectomy in patients with large vessel occlusion, including patients with basilar artery occlusion, with comparison across different ethnic groups.
Abstract
Background and Purpose The benefit regarding co-treatment with intravenous (IV) thrombolysis before mechanical thrombectomy in acute ischemic stroke with large vessel occlusion remains unclear. To test the hypothesis that clinical outcome of ischemic stroke patients with intracranial internal carotid artery, middle cerebral artery or basilar artery occlusion treated with direct endovascular thrombectomy within 4.5 hours will be non-inferior compared with that of standard bridging IV thrombolysis followed by endovascular thrombectomy. Methods To randomize 780 patients 1:1 to direct thrombectomy or bridging IV thrombolysis with thrombectomy. An international-multicenter prospective randomized open label blinded endpoint trial (PROBE) (ClincalTrials.gov identifier: NCT03494920). Results Primary endpoint is functional independence defined as modified Rankin Scale (mRS) 0–2 or return to baseline at 90 days. Secondary end points include ordinal mRS analysis, good angiographic reperfusion (modified Thrombolysis in Cerebral Infarction score [mTICI] 2b–3), safety endpoints include symptomatic intracerebral hemorrhage and death. Conclusions DIRECT-SAFE will provide unique information regarding the impact of direct thrombectomy in patients with large vessel occlusion, including patients with basilar artery occlusion, with comparison across different ethnic groups.
참고문헌 (23)
- Goyal M, "Endovascular thrombectomy after large-vessel ischaemic stroke : a meta-analysis of individual patient data from five randomised trials", Lancet, 387, pp.1723~1731 (2016)
- Emberson J, "Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials", Lancet, 384, pp.1929~1935 (2014)
- Ma H, "Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke", N Engl J Med, 380, pp.1795~1803 (2019)
- Berkhemer OA, "A randomized trial of intraarterial treatment for acute ischemic stroke", N Engl J Med, 372, pp.11~20 (2015)
- Suzuki Y, "A review of the mechanisms of blood-brain barrier permeability by tissue-type plasminogen activator treatment for cerebral ischemia", Front Cell Neurosci, 10, pp.2~ (2016)
- Wang W, "Hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke: mechanisms, models, and biomarkers", Mol Neurobiol, 52, pp.1572~1579 (2015)
- Anderson CS, "Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke", N Engl J Med, 374, pp.2313~2323 (2016)
- Gilgen MD, "Younger stroke patients with large pretreatment diffusion-weighted imaging lesions may benefit from endovascular treatment", Stroke, 46, pp.2510~2516 (2015)
- Saver JL, "Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke", N Engl J Med, 372, pp.2285~2295 (2015)
- Campbell BC, "Endovascular therapy for ischemic stroke with perfusion-imaging selection", N Engl J Med, 372, pp.1009~1018 (2015)
- Coutinho JM, "Combined intravenous thrombolysis and thrombectomy vs thrombectomy alone for acute ischemic stroke : a pooled analysis of the SWIFT and STAR studies", JAMA Neurol, 74, pp.268~274 (2017)
- Bhatia R, "Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke : real-world experience and a call for action", Stroke, 41, pp.2254~2258 (2010)
- McArthur KS, "Improving the efficiency of stroke trials : feasibility and efficacy of group adjudication of functional end points", Stroke, 44, pp.3422~3428 (2013)
- Mehta CR, "Adaptive increase in sample size when interim results are promising : a practical guide with examples", Stat Med, 30, pp.3267~3284 (2011)
- Churilov L, "An improved method for simple, assumption-free ordinal analysis of the modified Rankin Scale using generalized odds ratios", Int J Stroke, 9, pp.999~1005 (2014)
- Howard G, "A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes", Stroke, 43, pp.664~669 (2012)
- Altman DG, "The revised CONSORT statement for reporting randomized trials : explanation and elaboration", Ann Intern Med, 134, pp.663~694 (2001)
- Yang P, "Endovascular thrombectomy with or without intravenous alteplase in acute stroke", N Engl J Med, 382, pp.1981~1993 (2020)
- Suzuki K, "Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke : the SKIP randomized clinical trial", JAMA, 325, pp.244~253 (2021)
- Zi W, "Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke : the DEVT randomized clinical trial", JAMA, 325, pp.234~243 (2021)
- Roos Y, "Direct endovascular treatment (dEVT) versus intravenous alteplase followed by endovascular treatment in patients with acute stroke due to a large vessel occlusion", Proceedings of the International Stroke Conference 2021 (2021)
- Fischer U, "Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke (SWIFT DIRECT)", Proceedings of the 7th European Stroke Conference; (2021)
- Lin CH, "Endovascular thrombectomy without versus with intravenous thrombolysis in acute ischemic stroke : a non-inferiority meta-analysis of randomized clinical trials", J Neurointerv Surg (2021)[DOI]